We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Jefferson Scientists Find Tumor Suppressor Gene Also Protects Against Pre-Cancerous Development

The researchers say that the gene, caveolin-1 (Cav-1), could be a potential target for future drugs aimed at preventing breast cancer.
News

Ablynx Enters into a Research and License Agreement with Wyeth

Collaboration to discover, develop and commercialise Nanobodies® directed at the tumour necrosis factor alpha protein and its receptors that target diseases in multiple therapeutic areas.
News

Value of TaqMan® Drug Metabolism Genotyping Assays Validated

Scientists from Applied Biosystems presented data demonstrating the accuracy of TaqMan® Drug Metabolism Genotyping Assays in identifying variation in genes that code for drug metabolism enzymes.
News

Thermo Announces Process Laboratory Automation Seminars

The seminars focus on how advances in laboratory automation, using Laboratory Information Management Systems (LIMS), can act as a key enabler for improved productivity and quality in the process industry.
News

Thermo Announces Process Laboratory Automation Seminars

The seminars focus on how advances in laboratory automation, using Laboratory Information Management Systems (LIMS), can act as a key enabler for improved productivity and quality in the process industry.
News

DLReady Certification Awarded for Synergy 2 and Synergy HT Multi-Detection Microplate Readers

Awarded by Promega Corporation, this certification validates an instrument to the highest performance levels and standards for the Dual-Luciferase® Reporter Assay System.
News

Study Published in 'Nature Genetics' Utilizes SEQUENOM's MassARRAY System

The Department of Bioengineering at UCSD has implemented the MassARRAY® system to conduct automated high throughput mutation detection in microbial genomes and mixed microbial populations.
News

IntegraGen announces €2 million Equity Investment and R&D partnership with DSM Personalized Nutrition Group

IntegraGen is focused on the development of diagnostic and prognostic genetic tests for a range of complex diseases using its proprietary technology platform for gene identification.
News

ACD/Labs and SORD Work to Capture “Lost Chemistry”

The Selected Organic Reactions Database (SORD) is tapping into the vast reserves of chemical reaction information from academic research.
News

Introgen Obtains Exclusive License to Therapies Combining Epidermal Growth Factor Drugs and Tumor Suppressor Genes

Technology rights cover ADVEXIN or INGN 241 plus EGF inhibitors such as Vectibix, Erbitux, Tarceva and Iressa.
News

transADVANcis Launches the Website Assessment Customized Service

The service is oriented to life science and nano industries.
Advertisement